ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 680

$1.64M Total Retail Price of All Prescriptions

Rank: 16 out of 680

428 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

48% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 15,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,177 678 S3 1 4
BYSTOLIC 784 506 2 79
POTASSIUM CHLORIDE 747 510 3 14
FUROSEMIDE 663 474 4 6
OMEPRAZOLE 559 389 5 7
LEVOTHYROXINE SODIUM 477 374 6 2
CRESTOR 459 326 7 25
BENICAR HCT 446 290 10 8 150
AMLODIPINE BESYLATE 436 361 9 1
NAMENDA 408 338 10 35
NEXIUM 346 251 11 16
PRAVASTATIN SODIUM 344 250 12 10
GABAPENTIN 307 214 13 15
CIPROFLOXACIN HCL 297 214 14 57
WARFARIN SODIUM 292 220 15 20
ATORVASTATIN CALCIUM 264 147 16 11
CLONIDINE HCL 256 145 17 36
HYDROCHLOROTHIAZIDE 254 167 18 9
BENICAR 231 160 19 131
DONEPEZIL HCL 182 151 20 27
TAMSULOSIN HCL 179 135 21 34
LYRICA 178 113 22 77
METFORMIN HCL 173 118 23 8
ZOLPIDEM TARTRATE 173 108 23 17
AZITHROMYCIN 169 107 25 42
SIMVASTATIN 169 155 25 3
CLOPIDOGREL 165 130 27 26
LISINOPRIL 164 111 28 5
ISOSORBIDE MONONITRATE ER 164 155 28 59
AZOR 163 111 30 278
AVODART 152 111 31 218
SINGULAIR 142 82 32 91
ISOSORBIDE MONONITRATE 139 80 33 347
FLUTICASONE PROPIONATE 138 96 34 41
METFORMIN HCL ER 138 80 34 54
TRIBENZOR 137 101 36 321
RANITIDINE HCL 132 72 37 56
PLAVIX 131 115 38 39
COLCRYS 130 82 39 166
ADVAIR DISKUS 127 86 40 53
METHYLPREDNISOLONE 125 87 41 93
WELCHOL 124 74 42 223
TRAMADOL HCL 121 62 43 18
ESCITALOPRAM OXALATE 118 88 44 45
NYSTATIN-TRIAMCINOLONE 117 80 45 310
ONGLYZA 116 65 46 136
LIPITOR 115 89 47 68
CYCLOBENZAPRINE HCL 109 41 R 48 81
TRAZODONE HCL 108 74 49 48
DOXYCYCLINE HYCLATE 108 63 49 95
ULORIC 106 51 51 333
DEXILANT 106 66 51 171
RAMIPRIL 105 99 53 69
DALIRESP 103 71 54 392
AMITIZA 101 57 55 270
CLINDAMYCIN HCL 100 57 56 243
FLUCONAZOLE 100 56 56 139
PROAIR HFA 99 42 58 67
LANSOPRAZOLE 97 67 59 184
SEROQUEL XR 95 39 60 235
GLYBURIDE-METFORMIN HCL 94 67 R 61 107
CYMBALTA 93 75 62 46
DILTIAZEM 24HR ER 93 58 62 132
KLOR-CON M20 93 80 62 61
CEFACLOR 90 42 65 397
METOPROLOL SUCCINATE 90 72 65 13
DOXAZOSIN MESYLATE 89 85 67 73
ROPINIROLE HCL 88 67 68 99
ACETAMINOPHEN-CODEINE 87 39 S3 69 175
CELEBREX 84 81 70 90
NOVOLOG MIX 70-30 84 64 70 290
SPIRONOLACTONE 84 69 70 82
CEPHALEXIN 83 61 73 149
RANEXA 82 74 74 357
GLIMEPIRIDE 81 67 75 29
LOSARTAN-HYDROCHLOROTHIAZIDE 81 60 75 51
QUETIAPINE FUMARATE 79 64 77 64
PROMETHAZINE HCL 79 40 R 77 96
MONTELUKAST SODIUM 78 41 79 157
PANTOPRAZOLE SODIUM 78 45 79 30
HYDRALAZINE HCL 78 51 79 71
CARVEDILOL 76 39 82 23
PREDNISONE 72 46 83 50
AMITRIPTYLINE HCL 71 63 R 84 47
ZIPRASIDONE HCL 70 62 85 229
MULTAQ 70 56 85 374
EFFIENT 69 50 87 413
NAPROXEN 68 30 88 121
LEVEMIR FLEXPEN 67 18 89 186
METOCLOPRAMIDE HCL 65 48 90 118
MELOXICAM 65 42 90 24
LOSARTAN POTASSIUM 64 56 92 21
GLYBURIDE 62 35 R 93 85
ZETIA 62 30 93 87
SYMBICORT 60 36 95 208
IBANDRONATE SODIUM 58 55 96 288
FAMOTIDINE 58 53 96 89
PEN NEEDLE 58 21 96 122
ALLOPURINOL 57 41 99 33
ISOSORBIDE DINITRATE 57 40 99 227
LEVEMIR 56 25 101 248
LEXAPRO 56 42 101 128
GLIPIZIDE 55 44 103 63
ARICEPT 54 54 104 446
MUPIROCIN 54 40 104 130
CITALOPRAM HBR 53 45 106 22
GEMFIBROZIL 53 53 106 106
METHOCARBAMOL 52 36 R 108 251
NASONEX 52 28 108 197
NYSTATIN 52 31 108 191
ACIPHEX 51 31 111 372
JANUVIA 51 37 111 60
MEGESTROL ACETATE 50 40 R 113 88
DILTIAZEM 24HR CD 50 48 113 182
VENTOLIN HFA 50 29 113 202
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.